Medaccel
Medical affairs, scientific communications and education consultancy for pharmaceutical and biotech teams
Highlights
- Young companyFounded 2024
- New on EvolcAdded 2026-11-09
About Medaccel
MedAccel provides medical affairs strategy, advisory board design and insight synthesis, medical education, scientific communications, publications and patient resources. It also supports content review and approval through Veeva Vault PromoMats.
Its customers include pharma and biotech medical affairs and brand teams, medical communications agencies and education providers. Services include project delivery, white-label work and specialist support within client teams.
MedAccel Ltd is based in London and was founded in 2024. Its director is Dr Roya Elaine Haghighat-Khah.
Product: Medical affairs strategy, advisory boards, medical education, scientific communications, publication support and patient resources.
Jobs at Medaccel
More consulting & professional services companies
Media Asset Capital
Media strategy, technology and transaction consulting for broadcasters, content owners and media technology companiesNew on EvolcMedifintech
Fixed-fee NHS pension analysis and McCloud remedy support for NHS staff and their advisersNew on EvolcMedtech Integrity
Regulatory affairs and quality-system consulting for medical device and SaMD companies preparing for audits, scale or investmentYoung companyNew on EvolcMeinhardt (UK)
Multidisciplinary engineering consultancy serving property, infrastructure and built-environment clients in the UK and internationallyNew on EvolcMeiwood
Data and analytics consulting for organisations' data teams, focused on goals, accountability and operating modelsYoung companyNew on EvolcMellion Consulting
Customer reviews and survey consulting for organisations seeking to improve customer loyalty and retentionNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
No confirmed website technologies in the latest recorded checks.
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.
